Bank of New York Mellon Corp - CANTEL MEDICAL CORP ownership

CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 144 filers reported holding CANTEL MEDICAL CORP in Q4 2013. The put-call ratio across all filers is 2.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CANTEL MEDICAL CORP
ValueSharesWeighting
Q1 2021$38,045,000
-3.8%
476,499
-5.0%
0.01%
-11.1%
Q4 2020$39,558,000
+70.5%
501,612
-5.0%
0.01%
+50.0%
Q3 2020$23,206,000
+23.0%
528,151
+23.9%
0.01%
+20.0%
Q2 2020$18,861,000
+29.2%
426,407
+4.8%
0.01%0.0%
Q1 2020$14,601,000
-51.0%
406,734
-3.3%
0.01%
-37.5%
Q4 2019$29,815,000
-5.7%
420,516
-0.5%
0.01%
-11.1%
Q3 2019$31,606,000
-8.0%
422,550
-0.9%
0.01%0.0%
Q2 2019$34,370,000
+18.6%
426,217
-1.6%
0.01%
+12.5%
Q1 2019$28,970,000
-20.9%
433,125
-12.0%
0.01%
-27.3%
Q4 2018$36,627,000
-23.5%
491,984
-5.4%
0.01%
-8.3%
Q3 2018$47,865,000
+11.4%
519,929
+19.0%
0.01%0.0%
Q2 2018$42,981,000
-12.7%
436,983
-1.1%
0.01%
-14.3%
Q1 2018$49,207,000
+2.7%
441,680
-5.1%
0.01%
+7.7%
Q4 2017$47,896,000
+6.7%
465,602
-2.4%
0.01%
+8.3%
Q3 2017$44,906,000
+16.0%
476,866
-4.0%
0.01%
+9.1%
Q2 2017$38,718,000
-5.5%
496,968
-2.8%
0.01%0.0%
Q1 2017$40,969,000
-22.0%
511,475
-23.3%
0.01%
-26.7%
Q4 2016$52,528,000
+1.5%
667,024
+0.5%
0.02%0.0%
Q3 2016$51,738,000
+15.8%
663,474
+2.0%
0.02%
+7.1%
Q2 2016$44,694,000
-6.6%
650,272
-3.1%
0.01%0.0%
Q1 2016$47,863,000
+68.7%
670,735
+46.9%
0.01%
+55.6%
Q4 2015$28,372,000
+9.2%
456,593
-0.3%
0.01%
+12.5%
Q3 2015$25,978,000
+24.3%
458,169
+17.6%
0.01%
+33.3%
Q2 2015$20,907,000
+15.4%
389,546
+2.1%
0.01%
+20.0%
Q1 2015$18,124,000
-22.4%
381,538
-29.3%
0.01%
-16.7%
Q4 2014$23,357,000
+19.3%
539,909
-5.2%
0.01%
+20.0%
Q3 2014$19,573,000
-53.6%
569,310
-50.6%
0.01%
-16.7%
Q2 2014$42,222,000
+113.0%
1,152,944
+96.1%
0.01%
+20.0%
Q1 2014$19,824,000
+45.2%
587,922
+46.0%
0.01%
+25.0%
Q4 2013$13,653,000
-50.0%
402,642
-53.0%
0.00%0.0%
Q3 2013$27,282,000
+150.2%
856,594
+166.1%
0.00%
+33.3%
Q2 2013$10,902,000321,8470.00%
Other shareholders
CANTEL MEDICAL CORP shareholders Q4 2013
NameSharesValueWeighting ↓
DIKER MANAGEMENT LLC 1,383,325$136,064,00048.67%
Brown Capital Management 3,345,000$329,014,0003.38%
Kimelman & Baird, LLC 206,142$20,276,0002.66%
Conestoga Capital Advisors, LLC 690,673$67,935,0002.19%
WASATCH ADVISORS LP 1,772,992$174,391,0002.10%
Ranger Investment Management 280,989$27,638,0001.93%
Freedom Day Solutions, LLC 21,938$2,158,0001.76%
CAPITAL INSIGHT PARTNERS, LLC 17,853$1,756,0001.44%
Geller Advisors LLC 22,700$2,233,0000.97%
Sapphire Star Partners LP 8,607$846,0000.87%
View complete list of CANTEL MEDICAL CORP shareholders